Innes Meldrum
Directeur Général chez AdhereTech LLC
Profil
Innes Meldrum is currently the President & Chief Executive Officer at AdhereTech LLC since 2023 and also the Director at Otsuka Canada Pharmaceutical, Inc. since 2020.
In the past, she worked as the President, Chief Executive Officer & Director at Reset Pharmaceuticals, Inc.
Postes actifs de Innes Meldrum
| Sociétés | Poste | Début |
|---|---|---|
Otsuka Canada Pharmaceutical, Inc.
 Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide. | Directeur/Membre du Conseil | 18/03/2020 |
AdhereTech LLC
 AdhereTech LLC Electronic Equipment/InstrumentsElectronic Technology AdhereTech LLC provides prescription drug packaging solutions. The firm develops smart pill bottle that enables to know when pills and liquid medication is missed by patients. The company was founded by Josh Stein and is headquartered in New York, NY. | Directeur Général | 06/09/2023 |
Anciens postes connus de Innes Meldrum
| Sociétés | Poste | Fin |
|---|---|---|
Reset Pharmaceuticals, Inc.
 Reset Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reset Pharmaceuticals, Inc. is a clinical-stage biotechnology company that focuses on developing and commercializing novel treatments for patients suffering from mental illness related to life-altering diseases. Reset Pharmaceuticals is based in Great Neck, NY and was founded by Philip Taub and Jan-Anders Karlsson. The company's lead product candidate, the oral psilocybin, is being developed to treat demoralization syndrome in patients with cancer. Reset Pharma has a highly experienced team with a strong track record of successful development, approvals, and launches of neuroscience drugs. The company also has a scientific advisory board of key opinion leaders in psychiatry, oncology, and psychedelics, as well as a strategic advisory board of business leaders and financial experts. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Otsuka Canada Pharmaceutical, Inc.
Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide. | Health Technology |
Reset Pharmaceuticals, Inc.
Reset Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reset Pharmaceuticals, Inc. is a clinical-stage biotechnology company that focuses on developing and commercializing novel treatments for patients suffering from mental illness related to life-altering diseases. Reset Pharmaceuticals is based in Great Neck, NY and was founded by Philip Taub and Jan-Anders Karlsson. The company's lead product candidate, the oral psilocybin, is being developed to treat demoralization syndrome in patients with cancer. Reset Pharma has a highly experienced team with a strong track record of successful development, approvals, and launches of neuroscience drugs. The company also has a scientific advisory board of key opinion leaders in psychiatry, oncology, and psychedelics, as well as a strategic advisory board of business leaders and financial experts. | Health Technology |
AdhereTech LLC
AdhereTech LLC Electronic Equipment/InstrumentsElectronic Technology AdhereTech LLC provides prescription drug packaging solutions. The firm develops smart pill bottle that enables to know when pills and liquid medication is missed by patients. The company was founded by Josh Stein and is headquartered in New York, NY. | Electronic Technology |
